Related Experiment Video
Updated: Aug 20, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions
Jordan Taylor1, Henry R Stiepel1, Nicole Keefe1
1Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Insights
Effective peripheral artery disease revascularization requires careful management of clotting. Post-procedure care involves selecting appropriate anticoagulant and antiplatelet agents based on patient factors to improve cardiovascular outcomes.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Pharmacology
Background:
- Peripheral artery disease (PAD) revascularization necessitates precise control of the clotting cascade.
- Post-procedural management is critical for optimizing patient outcomes and preventing complications.
Purpose of the Study:
- To guide interventionalists in selecting appropriate pharmacotherapy for post-revascularization management.
- To review anticoagulant and antiplatelet agents for patients with peripheral artery disease.
Main Methods:
- Review of current literature on anticoagulant and antiplatelet therapies.
- Discussion of patient-specific factors influencing medication choice, including cardiovascular risk, contraindications, and psychosocial elements.
Main Results:
- Effective revascularization depends on periprocedural pharmacological regulation.
- Individualized treatment plans considering patient factors are essential for post-revascularization care.
- Familiarity with available medication classes is crucial for improving cardiovascular outcomes.
Conclusions:
- Optimal post-revascularization management requires a tailored approach to pharmacotherapy.
- Anticoagulant and antiplatelet agents play a vital role in improving outcomes for PAD patients.
- Interventionalists must be knowledgeable about medication options to enhance patient cardiovascular health.
Abstract:
Effective revascularization of peripheral artery disease relies on periprocedural pharmacological regulation of the clotting cascade. Patient-specific factors such as cardiovascular risk factors, contraindications, and individual psychosocial factors must be considered when initiating post revascularization management. Management with anticoagulant and antiplatelet agents is discussed to guide the interventionalist on which therapy may be appropriate for their patient. While exact treatment may be institution and provider dependent, the interventionist must be familiar with the available classes of medications and how they can be prescribed in the postprocedural setting to improve cardiovascular outcomes.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction